Loading insider details...
Latest Form 4 (Aug 14, 2026): Purchase of 101,010 OTLK shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 101,010 | n/a |
| Jul 23, 2026 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 210,078 | n/a |
| Sep 30, 2024 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 5,000 | $28.4K |
| Mar 22, 2024 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 12,500 | n/a |
| Apr 20, 2021 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 10,000 | $18.3K |
| Oct 5, 2020 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 3,668,984 | n/a |
| Jul 21, 2020 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 450,000 | n/a |
| Mar 20, 2020 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 216,435 | n/a |